Global health authorities use WHO situation reports and joint missions to review epidemiological data, case fatality rates, and geographic spread of highly pathogenic avian influenza. These reports summarize confirmed human cases, exposure risks, and changes in virus behavior, including mutations that may increase transmissibility or severity. WHO coordinates with national health ministries to strengthen laboratory capacity, reporting timelines, and rapid response teams in countries with ongoing outbreaks. Detailed situation updates and technical guidance are published through the WHO disease outbreak news portal at who.int/emergencies/disease-outbreak-news.
Human Health Risks, Symptoms, and Case Data
Human infections with bird flu viruses are rare but can cause severe respiratory illness, with symptoms including fever, cough, shortness of breath, and pneumonia. WHO reports that case fatality rates vary by subtype and region, with H5N1 infections historically associated with high severity and frequent hospitalization. The organization advises countries to rapidly investigate suspected cases, collect samples for laboratory confirmation, and share genetic sequence data to monitor viral evolution. WHO clinical management guidelines for avian influenza are available at who.int/publications/m/item/clinical-management-of-acute-respiratory-infection-when-novel-coronavirus-infection-is-suspected.
WHO tracks confirmed human cases through the Global Influenza Surveillance and Response System, which includes national laboratories and collaborating centers that analyze virus samples and report findings. The organization issues recommendations for antiviral treatment, infection prevention in healthcare settings, and protective measures for people in direct contact with poultry or wild birds. WHO emphasizes that sustained human-to-human transmission has not been widely documented for current H5N1 clades, but the risk remains under continuous assessment. Technical reports on human cases and risk factors are published through the WHO influenza surveillance hub at who.int/teams/global-influenza-programme.
Global Preparedness, Coordination, and Response Measures
WHO supports pandemic preparedness by maintaining a global influenza surveillance network, updating pandemic risk assessments, and coordinating stockpiling plans for vaccines and antivirals. The organization works with manufacturers and regulatory agencies to evaluate candidate vaccine viruses and facilitate technology transfer for low- and middle-income countries. WHO also provides guidance on biosafety, biosecurity, and outbreak investigation protocols for laboratories handling avian influenza samples. WHO pandemic preparedness resources are accessible at who.int/teams/risk-management/pandemic-preparedness.
WHO convenes emergency committees and technical advisory groups to review evidence on virus evolution, host range, and severity, and to issue temporary recommendations for member states. The organization coordinates with the Coalition for Epidemic Preparedness Innovations and other partners to accelerate vaccine development and regulatory approval pathways. WHO country offices assist national authorities in strengthening surveillance systems, laboratory diagnostics, and risk communication during outbreaks. WHO emergency preparedness frameworks and guidance documents are available at